coronavirus differ and how soon after infection a patient might be at risk again.The team’s findings could have major implications for vaccine research and help to predict an individual’s risk of developing serious complications related to COVID-19, but one of the study’s lead researchers warns the findings won’t lead to any ironclad declarations of COVID immunity among recovered patients.A team of researchers with the University of Ottawa and The Ottawa Hospital will study COVID-19 antibody and T cell responses from 1,000 subjects over the next 10 months.
In an infection, T cells target infected cells and help to stimulate B cells, which then produce antibodies to neutralize pathogens and label them for disruption.Half of the study.